Smith and Sapphire Bio-Tech Limited

Smith and Sapphire Bio-Tech Limited - pharma in New Delhi, Delhi, India. Directors, charges & compliance details.
CIN U74899DL1995PLC065063 Incorporated 03 February 1995 ROC Delhi HQ New Delhi, Delhi, India
Active Public Limited Company pharma
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹4 Cr
Issued & subscribed
Open charges
₹1.84 Cr
Secured borrowings
Company age
31 yrs
Est. 1995
Directors on board
3
As per MCA filings
Last financials
Mar 2011
Balance sheet date
Last AGM
28 Sep 2011
Annual general meeting
Company status
Active
MCA master data

About Smith and Sapphire Bio-Tech Limited

Data last updated:

Smith and Sapphire Bio-Tech Limited is a public limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 February 1995 and has been in existence for over 31 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1995PLC065063.

The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹4 Cr. It is led by directors including Rohit Choudhary Kumar and Mahmud Kazi.

Its last annual general meeting (AGM) was held on 28 September 2011, and its latest financial statements are for the year ended 31 March 2011. The registered office is at C – 128/1 First Floor Mohammadpur Bhikaji Cama Place, New Delhi, Delhi, India – 110066.

As per MCA filings, the company has open charges of ₹1.84 Cr on record.

The current compliance status is marked as active non-compliant by the Registrar of Companies.

Company details

CIN U74899DL1995PLC065063
Registration Number 065063
Incorporation Date 03 February 1995
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Non-Compliant

Contact details

Smith and Sapphire Bio-Tech Limited's registered office is in New Delhi, Delhi.

  • Registered Address
    C – 128/1 First Floor Mohammadpur Bhikaji Cama Place, New Delhi, Delhi, India – 110066
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Smith and Sapphire Bio-Tech Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Smith and Sapphire Bio-Tech Limited

FY 2011 filings available

Financial Statement Summary

MetricsFY 2010-11
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2010-11
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Smith and Sapphire Bio-Tech Limited, buy the company report.

Board of directors of Smith and Sapphire Bio-Tech Limited

Smith and Sapphire Bio-Tech has 3 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rohit Choudhary KumarDirector28 May 201610 Years 5 MonthsCurrent
Mahmud KaziDirector28 May 201610 Years 5 MonthsCurrent
Dilip Kumar PandeyDirector28 May 201610 Years 5 MonthsCurrent

Charges & borrowings

Open charges
₹1.84 Cr
Satisfied charges
None
Breakdown by lending institutions
Oriental Bank of Commerce₹1.04 Cr
Punjab National Bank₹0.80 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
12 Aug 201310446008Oriental Bank of Commerce₹14.35 LakhOpen
12 Dec 201210496310Oriental Bank of Commerce₹90 LakhOpen
24 Oct 200910190078Punjab National Bank₹80 LakhOpen

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Smith and Sapphire Bio-Tech Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Smith and Sapphire Bio-Tech Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Smith and Sapphire Bio-Tech Limited has 16 board changes on record since 2011: 3 appointments and 13 cessations. The latest: Dilip Kumar Pandey was appointed as Director on 28 May 2016.

Appointed
Dilip Kumar Pandey was appointed as Director.
Appointed
Mahmud Kazi was appointed as Director.
Ceased
Rajesh Kumar ceased to be Director.
Appointed
Rohit Choudhary Kumar was appointed as Director.
Ceased
Rohit Choudhary Kumar ceased to be Director.
Ceased
Sambhu Singh ceased to be Director.
Ceased
Sanjeev Singh ceased to be Director.
Ceased
Ashok Kumar ceased to be Director.
Ceased
Inderjeet Arora ceased to be Director.
Ceased
Nishan Gujra Singh ceased to be Director.
Ceased
Neeraj Garg ceased to be Director.
Charges
A charge with Oriental Bank Of Commerce amounted to Rs. 0.14 Cr with Charge ID 10446008 was registered on 12 Aug 2013.

10 earlier events are in the company report.

Frequently asked questions

Smith and Sapphire Bio-Tech is an active public limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 February 1995 (31+ years old) and is registered under CIN U74899DL1995PLC065063.

Smith and Sapphire Bio-Tech has 3 current directors:

The latest financial statements of Smith and Sapphire Bio-Tech on record with the MCA are for the year ended 31 March 2011. Its last annual general meeting was held on 28 September 2011. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Smith and Sapphire Bio-Tech is U74899DL1995PLC065063. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Smith and Sapphire Bio-Tech was incorporated on 03 February 1995, making it 31+ years old. It is registered with the Registrar of Companies, Delhi.

Dilip Kumar Pandey was appointed as Director on 28 May 2016. Mahmud Kazi was appointed as Director on 28 May 2016. Rajesh Kumar ceased to be Director on 28 May 2016. Smith and Sapphire Bio-Tech has 16 board changes on record in total.

The registered office of Smith and Sapphire Bio-Tech is at C – 1281 First Floor Mohammadpur Bhikaji Cama Place, New Delhi, Delhi, India – 110066.

Smith and Sapphire Bio-Tech operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

Smith and Sapphire Bio-Tech has open charges of ₹1.84 Cr and no satisfied charges on record as per latest MCA filings.

The compliance status of Smith and Sapphire Bio-Tech is active non-compliant as of 28 September 2026. The company is actively filing with the Registrar of Companies.